Literature DB >> 8752814

Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy.

M J Kofflard1, L A van Herwerden, D J Waldstein, P Ruygrok, E Boersma, M A Taams, F J Ten Cate.   

Abstract

OBJECTIVES: The purpose of this study was to describe the clinical and functional results of combined anterior mitral leaflet extension and myectomy in patients with hypertrophic obstructive cardiomyopathy.
BACKGROUND: Septal myectomy is the most commonly performed surgical procedure in patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction. Because of the role of the mitral valve in creating the outflow tract gradient, mitral valve replacement or plication is performed in selected cases in combination with myectomy, often with better hemodynamic results than those of myectomy alone. Mitral valve leaflet extension, in which a glutaraldehyde-preserved autologous pericardial patch is used to enlarge the mitral valve along its horizontal axis, is a novel surgical approach in patients with hypertrophic obstructive cardiomyopathy.
METHODS: Eight patients with hypertrophic obstructive cardiomyopathy were treated with mitral leaflet extension and myectomy. Preoperative and postoperative data (New York Heart Association functional class, number of drugs prescribed, width of the interventricular septum, severity of mitral valve regurgitation severity of systolic anterior motion of the mitral valve and outflow tract gradient) were compared with those of 12 patients undergoing myectomy alone.
RESULTS: Preoperative evaluation demonstrated that mitral regurgitation and systolic anterior motion of the mitral valve were more severe in the group undergoing mitral valve extension (p < 0.001 and p < 0.05, respectively). There were no deaths associated with either surgical procedure. Two patients, both treated by myectomy alone, died during the follow-up period. Postoperatively, patients treated with mitral valve extension had less mitral regurgitation (p < 0.005), less residual systolic anterior motion (p < 0.001), greater improvement in functional class (p = 0.05) and greater reduction in the number of drugs (p < 0.005) and in septal thickness (p < 0.05).
CONCLUSIONS: Mitral leaflet extension in combination with myectomy is a promising new surgical approach that may provide superior results to those of myectomy alone. Further studies are needed to determine the clinical value of this procedure.

Entities:  

Mesh:

Year:  1996        PMID: 8752814     DOI: 10.1016/0735-1097(96)00103-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

Review 1.  Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Joon Hwa Hong; Anita Nguyen; Hartzell Vernon Schaff
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-07

2.  Long-term outcome of simultaneous septal myectomy and anterior mitral leaflet retention plasty in hypertrophic obstructive cardiomyopathy: the Berlin experience.

Authors:  Eva Maria Delmo Walter; Mariano Francisco Javier; Roland Hetzer
Journal:  Ann Cardiothorac Surg       Date:  2017-07

Review 3.  The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.

Authors:  Albert A Hagège; Patrick Bruneval; Robert A Levine; Michel Desnos; Hany Neamatalla; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2011-09-10       Impact factor: 4.132

4.  Percutaneous transluminal septal myocardial ablation (PTSMA) for symptomatic patients with hypertrophic obstructive cardiomyopathy: first experience.

Authors:  J M Ten Berg; H H D Idzerda; W Jaarsma
Journal:  Neth Heart J       Date:  2001-11       Impact factor: 2.380

5.  DDDR pacing for symptomatic patients with hypertrophic obstructive cardiomyopathy: The first experience in the Netherlands with pacing in HOCM.

Authors:  H J Achterberg; M G Scheffer; R van Mechelen; M J M Kofflard; F J Ten Cate
Journal:  Neth Heart J       Date:  2002-06       Impact factor: 2.380

6.  Contribution of mitral valve leaflet length and septal wall thickness to outflow tract obstruction in patients with hypertrophic cardiomyopathy.

Authors:  Kareem Morant; Yoko Mikami; Immaculate Nevis; David McCarty; John Stirrat; David Scholl; Martin Rajchl; Peter Giannoccaro; Louis Kolman; Bobby Heydari; Carmen Lydell; Andrew Howarth; Andrew Grant; James A White
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-08       Impact factor: 2.357

Review 7.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

8.  Keynote Lecture-Transmitral hypertrophic obstructive cardiomyopathy (HOCM) repair.

Authors:  Friedrich W Mohr; Joerg Seeburger; Martin Misfeld
Journal:  Ann Cardiothorac Surg       Date:  2013-11

Review 9.  Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management.

Authors:  C Charles Jain; Darrell B Newman; Jeffrey B Geske
Journal:  Curr Cardiol Rep       Date:  2019-10-31       Impact factor: 2.931

Review 10.  Hypertrophic cardiomyopathy: a review.

Authors:  Brian A Houston; Gerin R Stevens
Journal:  Clin Med Insights Cardiol       Date:  2015-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.